BlackRock Fund Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $266K | Buy |
20,892
+597
| +3% | +$7.6K | ﹤0.01% | 3353 |
|
|
2016
Q3 | $372K | Sell |
20,295
-41
| -0.2% | -$752 | ﹤0.01% | 3292 |
|
|
2016
Q2 | $216K | Sell |
20,336
-170,678
| -89% | -$1.81M | ﹤0.01% | 3421 |
|
|
2016
Q1 | $3.61M | Sell |
191,014
-10,392
| -5% | -$196K | ﹤0.01% | 2906 |
|
|
2015
Q4 | $5.36M | Buy |
201,406
+5,605
| +3% | +$149K | ﹤0.01% | 2803 |
|
|
2015
Q3 | $8.93M | Sell |
195,801
-1,307
| -0.7% | -$59.6K | ﹤0.01% | 2441 |
|
|
2015
Q2 | $6.35M | Sell |
197,108
-13,238
| -6% | -$426K | ﹤0.01% | 2786 |
|
|
2015
Q1 | $6.69M | Buy |
210,346
+4,138
| +2% | +$132K | ﹤0.01% | 2673 |
|
|
2014
Q4 | $7.8M | Buy |
206,208
+30,030
| +17% | +$1.14M | ﹤0.01% | 2615 |
|
|
2014
Q3 | $4.65M | Sell |
176,178
-8,248
| -4% | -$218K | ﹤0.01% | 2797 |
|
|
2014
Q2 | $5.46M | Buy |
184,426
+15,805
| +9% | +$468K | ﹤0.01% | 2785 |
|
|
2014
Q1 | $6.24M | Buy |
168,621
+6,788
| +4% | +$251K | ﹤0.01% | 2683 |
|
|
2013
Q4 | $6.7M | Sell |
161,833
-7,408
| -4% | -$307K | ﹤0.01% | 2629 |
|
|
2013
Q3 | $8.97M | Buy |
169,241
+19,372
| +13% | +$1.03M | ﹤0.01% | 2440 |
|
|
2013
Q2 | $8M | Buy |
+149,869
| New | +$8M | ﹤0.01% | 2396 |
|